CPVT is mostly linked with single-point mutations in the cardiac ryanodine receptor gene (RYR2) but also in cardiac calsequestrin isoform 2 (CASQ2) gene and, even more recently identified, in triadin (TRDN) [168]. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.